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Myocardial norepinephrine is markedly reduced after 
cardiac transplantation because of interruption of post•
ganglionic cardiac sympathetic nerves. There are also 
substantial stores of dopamine in the myocardium, but 
the influence of cardiac denervation on dopamine re•
mains unknown. The effect of cardiac transplantation 
was determined and, thus, the effect of denervation on 
myocardial norepinephrine, dopamine and epinephrine. 
Myocardial catecholamines were measured with high•
performance liquid chromatography with electrochem•
ical detection in five dogs 6 to 8 weeks and in four dogs 
8 to 12 years after cardiac autotransplantation and in 
six sham-operated dogs with intact cardiac innervation. 
Norepinephrine, dopamine and epinephrine levels were 
determined from samples obtained from the right and 
left atria and ventricles. Samples from the left ventric•
ular apex and base were analyzed separately. There was 
a striking depletion of norepinephrine in all cardiac 
chambers after short-term autotransplantation. The 
norepinephrine content of the left atrium in sham-op-
The heart is richly innervated by the adrenergic nervous 
system, which is important in circulatory control. With in•
tact cardiac innervation, myocardial catecholamine stores 
are large (1-3). However, cardiac denervation after heart 
transplantation depletes the myocardium of norepinephrine 
and possibly epinephrine because of interruption of post•
ganglionic cardiac sympathetic nerves (4). Previous studies 
(5-7) have demonstrated low myocardial norepinephrine 
and epinephrine levels up to 5 years after cardiac trans-
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erated dogs (1,659 ± 219 nglg) was significantly higher 
than that of dogs with long-term autotransplanted hearts 
(754 ± 372 nglg). Sham-operated dogs and dogs with 
long-term autotransplanted hearts had statistically sig•
nificant (p < 0.05) differences in norepinephrine content 
in the left ventricular apex (480 ± 197 versus 294 ± 
198 nglg), left ventricular base (876 ± 2204 versus 654 
± 156 nglg) and right ventricle (766 ± 133 versus 247 
± 29 ng/g). 
In contrast to norepinephrine, dopamine concentra•
tions were relatively preserved in the short-term group 
despite the virtual depletion of myocardial norepineph•
rine. The data confirm that cardiac denervation depletes 
myocardial norepinephrine in all portions of the trans•
planted heart and that norepinephrine levels remain de•
pressed up to 12 years after transplantation. The data 
also demonstrate that dopamine levels are only modestly 
decreased compared with norepinephrine levels (p = 
NS). 
(J Am Coil CardioI1986;7:419-24) 
plantation when there is functional evidence for efferent 
sympathetic reinnervation of the heart (7), but the extent of 
reinnervation after longer periods is unknown. Although the 
effect of cardiac denervation on myocardial stores of nor•
epinephrine and epinephrine has been studied previously, 
little is known about the effect of cardiac transplantation on 
myocardial dopamine levels. 
The purpose of our study was twofold: I) to assess myo•
cardial norepinephrine, dopamine and epinephrine concen•
trations in autotransplanted canine hearts 6 to 8 weeks (short•
term) and 8 to 12 years (long-term) after transplantation; 
and 2) to determine whether dopamine content in cardiac 
tissue is dependent on intact innervation in a manner similar 
to that reported previously for norepinephrine. We measured 
myocardial norepinephrine, epinephrine and dopamine con•
tent in dogs 6 to 8 weeks and 8 to 12 years after cardiac 
autotransplantation and in sham-operated dogs (thoracotomy 
and pericardiotomy). The data from these three groups of 
dogs allowed us to compare the catecholamine content in 
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different cardiac chambers of the heart with intact inner•
vation with that of short-term autotransplanted denervated 
hearts and long-term reinnervated autotransplanted hearts. 
Methods 
Nine mongrel dogs underwent orthotopic cardiac auto•
transplantation by the technique of Lower et al. (8) and were 
studied 6 to 8 weeks and 8 to 12 years after transplantation 
for evidence of afferent reinnervation and myocardial nor•
epinephrine, epinephrine and dopamine concentrations. Six 
sham-operated (thoracotomy and pericardiotomy) dogs with 
intact cardiac innervation served as control animals. 
Experimental preparation. Fifteen mongrel dogs 
weighing 15 to 32 kg were anesthetized with thiopental 
sodium (20 mg/kg body weight intravenously) and alpha•
chloralose (80 mg/kg initially and 10 mg/kg intravenously 
hourly). After endotracheal intubation, the dogs were me•
chanically ventilated with air supplemented with oxygen. 
Blood oxygen and carbon dioxide tensions (Po2, PC02) and 
pH were measured periodically. When necessary, sodium 
bicarbonate (2 to 5 ml of a 7% solution) was given to 
maintain pH between 7.3 and 7.4 and the ventilatory rate 
was adjusted to keep PC02 between 30 and 40 torr. Arterial 
P02 was greater than 100 torr in all studies. Body temper•
ature was maintained between 37 and 39°C by external 
warming. During the protocol, muscle movement was pre•
vented with pancuronium bromide (0.3 to 1 ml intrave•
nously) administered as needed. Physiologic studies as de•
scribed elsewhere (9) were carried out to assess the extent 
of afferent vagal reinnervation and results are reported in a 
companion article (9). After completion of these studies, 
the dogs were killed by intravenous injection of saturated 
potassium chloride solution. 
Cardiac tissue sampling. The hearts were removed im•
mediately and washed with cold saline solution. Care was 
taken to obtain the samples as rapidly as possible from the 
right and left atrial appendages and lateral walls of the right 
and left atria. Subsequently, the atria and great vessels were 
removed and discarded. Samples from the apexes of the 
right and left ventricles were obtained after excision of tri•
cuspid and mitral valves. Finally, myocardial tissue was 
obtained from the left ventricular base. All tissue samples 
were transmural and free of epicardial fat. The samples were 
immediately frozen in liquid nitrogen and stored at - 70°C 
for subsequent analysis. 
Catecholamine assays. Catecholamines were isolated 
from the myocardial tissue by column separation techniques, 
as described previously by Eriksson and Persson (10). Eluted 
catecholamines were then measured by high-performance 
liquid chromatography employing electrochemical detection 
(11,12). 
Sample preparation. The frozen tissue was cut into small 
pieces, weighed and placed in a homogenizer. One milliliter 
of perchloric acid (0.1 mollliter) containing ethylenediami-
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netetraacetic acid (EDT A) (3.0 mmol/liter) and 0.1 mmol/liter 
of the internal standard dihydroxybenzylamine (DHBN) was 
added per 0.1 g of tissue and homogenized in an ice bath. 
Two milliliter aliquots of the supernatant were transferred 
to 5 ml polypropylene serum vials and frozen at - 70°C if 
not analyzed immediately. 
Alumina absorption. Fifty liters of reduced glutathione 
(50 mmollliter), 50 liters of EDT A (0.3 mollliter, pH 0.7), 
20 ml of acid-washed alumina and 2.0 ml of TRIS buffer 
(l mol/liter, pH 8.6) were added to each 2.0 ml of tissue 
supernatant in the polypropylene tubes. The samples were 
shaken until all of the supernatant was defrosted. The entire 
content of the tube was then poured into an empty poly•
propylene column (Isolab Inc.) and the alumina was washed 
with 20 ml of EDTA (0.3 mollliter, pH 7) over vacuum. 
After the final washing, the columns were centrifuged to 
remove excess liquid. The amines were eluted from the 
alumina by vortexing for 45 seconds with 200 liters of 
perchloric acid (0.1 mol/liter). After centrifugation, the tubes 
were stored frozen in darkness and were thawed just before 
injection into the chromatographic column. 
Chromatography. One hundred microliters of the eluate 
was injected into a Brownlee RP-C 18 spheri-5 column 
attached to a Spectra physics 8100 high-performance liquid 
chromatograph and 5100 A electrochemical detector equipped 
with a SOil electrode (Environmental Science). The mobile 
phase consisted of 1) 92% of solution containing mono•
chloracetic acid (0.1 mollliter), EDTA (0.1 mmollliter) and 
sodium octyl sulfate (0.8 g/liter) at pH 3.0; and 2) 8% 
solution of acetonitrile. The mobile phase flow rate was 1.4 
ml/min and the solution was recycled while being constantly 
degassed with helium. The postcolumn electrodes were set 
at 0.07 and 0.37 V. The output from the last electrode was 
displayed on a Spectraphysics 4200 computer integrator. 
The reference samples of norepinephrine, epinephrine and 
dopamine were used as standards; the method of extraction 
was similar to that used for the tissue samples. The analytical 
recovery through the alumina extraction was 95% for the 
standards and 70% for the tissue sample based on the internal 
standard DHBA. The intraassay variation was 10% and the 
sensitivity was less than 5 pglrnl for all three catecholarnines. 
Statistics. The statistical significance of differences in 
myocardial norepinephrine, epinephrine and dopamine lev•
els between groups and within groups for several variables 
was determined by analysis of variance. The probability 
level of 0.05 was used as the criterion of significance. Data 
are presented as mean ± SE. Catecholamine concentrations 
are expressed in nanograms per gram wet weight of tissue. 
Results 
Myocardial norepinephrine content. The hearts from 
dogs with a sham operation and, thus, with normal inner•
vation had a higher (p < 0.05) concentration of norepi•
nephrine in the atria than in the ventricles, which confirms 
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Figure 1. Myocardial norepinephrine concentrations in the heart 
of six sham-operated (normal control) dogs versus four dogs with 
long-term (8 to 12 years) autotransplanted hearts. 
previous observations (6,12,13). The difference in norepi•
nephrine concentration between the atria and ventricles as 
well as the regional differences within the left ventricle (base 
and apex) (13) observed in the sham-operated group also 
were noted in long-term autotransplanted hearts (Fig. 1), 
even though the values were still low compared with those 
in sham-operated innervated hearts. 
The norepinephrine content of the left atrium in the sham•
operated group (1,659 ± 291 ng/g) was significantly higher 
than that of long-term autotransplanted hearts (753 ± 372 
ng/g). The differences in norepinephrine content in the left 
ventricular apex (480 ± 197 in the sham-operated group 
versus 294 ± 198 nglg in the long-term group), left ven•
tricular base (876 ± 204 versus 654 ± 156 ng/g) and right 
ventricle (766 ± 133 versus 247 ± 28 ng/g) were statis•
tically significant despite the small number of dogs studied. 
In contrast, the short-term (6 to 8 weeks postoperative) 
autotransplanted hearts demonstrated (Fig. 2) almost com•
plete depletion of norepinephrine in all cardiac chambers 
consistent with results from previous studies (4-6). Myo•
cardial norepinephrine concentrations of all cardiac cham•
bers were significantly higher in the long-term than in the 
short-term group, which had virtual total depletion of nor•
epinephrine (Fig. 1 and 2). 
Myocardial epinephrine content (Fig. 3 and 4). 
Epinephrine concentration did not exhibit a distinct regional 
pattern (that is, atria versus ventricles), although levels were 
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Figure 2. Myocardial norepinephrine concentrations in the heart 
of six sham-operated dogs versus five dogs with short-term (3 to 
6 weeks) autotransplanted hearts. 
Figure 3. Myocardial epinephrine concentrations in the heart of 
six sham-operated dogs versus five dogs with short-term (3 to 6 
weeks) autotransplanted hearts. 
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Figure 4. Myocardial epinephrine concentrations in the heart of 
six sham-operated dogs versus four dogs with long-term (8 to 12 
years) autotransplanted hearts. 
markedly decreased in all four cardiac chambers after short•
term autotransplantation (Fig. 3). The levels in both the 
right and left ventricles remained equally decreased even 8 
to 12 years after transplantation. Atrial epinephrine levels 
returned to control levels over the long term (Fig. 4). 
Myocardial dopamine (Fig. 5 and 6). Dopamine con•
centration tended to be somewhat lower after short-term and 
long-term transplantation; however, the differences between 
the sham-operated and short-term group and between the 
sham-operated and long-term group were not statistically 
significant. This result may have been due to the small 
number of animals from which data were obtained. How•
ever, myocardial dopamine concentration in short-term de•
nervated hearts lacked the striking pattern of depletion seen 
for myocardial norepinephrine concentration (Fig. 5). Fur•
thermore, dopamine levels did not differ significantly in the 
long- and short-term groups and, thus, did not manifest the 
trend toward higher values seen for norepinephrine concen•
tration with time after transplantation. 
Discussion 
The results of our study suggest that intact adrenergic 
innervation of the heart is the principal determinant of myo•
cardial norepinephrine levels (4-7), whereas dopamine con•
centration in cardiac tissue is in large part independent of 
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Figure 5. Myocardial dopamine concentrations in the heart of six 
sham-operated dogs versus five dogs with short-term (3 to 6 weeks) 
autotransplanted hearts. 
sympathetic innervation. In recent years various assay tech•
niques for the quantitation of catecholamines (10-12) have 
significantly enhanced our knowledge about myocardial tis•
sue catecholamine levels in normal (14) and pathologic states 
(15,16). Our study, employing the canine autotransplant 
model, was conducted to characterize the distribution of 
catecholamines (norepinephrine, dopamine, epinephrine) in 
different cardiac chambers and to assess the effect of de•
nervation and reinnervation on myocardial catecholamine 
concentrations. Because functional efferent reinnervation 
appears to be extensive at 12 to 24 months (17), we used 
Figure 6. Myocardial dopamine concentrations in the heart of six 
sham-operated dogs versus four dogs with long-term (8 to 12 years) 
auto transplanted hearts. 
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the short-term (6 to 8 weeks post-transplant) autotrans•
planted hearts to evaluate the effects of denervation on cate•
cholamine levels. We then compared these results with those 
from long-term (8 to 12 years) autotransplanted hearts. Dogs 
with sham-operated hearts with intact cardiac innervation 
served as normal control animals. The data from sham•
operated dog hearts showed that there was a higher con•
centration of norepinephrine in the atria than in the ventri•
cles. Dopamine levels also tended to be higher in the atria 
than in the ventricles, although the difference in dopamine 
content was not significant. Epinephrine content in the atria 
and ventricles was similar in mean value with a large var•
iability for the control group. Shortly after autotransplan•
tation of the heart, epinephrine was decreased in all four 
cardiac chambers. In the long-term, atrial epinephrine levels 
returned to the levels observed in the sham-operated group 
while ventricular levels remained markedly decreased. 
Myocardial tissue norepinephrine and functional 
reinnervation. Our data on myocardial norepinephrine in 
normal canine hearts are in agreement with similar mea•
surements reported from a number of laboratories using a 
variety of assay techniques (1-3,13,14). The regional left 
ventricular differences in norepinephrine concentration ob•
served between base and apex are similar to those reported 
by others (13,14). Shortly after cardiac autotransplantation, 
there was a striking decrease of norepinephrine content, but 
dopamine concentration did not demonstrate a significant 
change. In the long-term group, myocardial norepinephrine 
levels increased with regional differences in norepinephrine 
levels, particularly those in the left ventricle, redeveloping 
with reinnervation. 
Although evidence for extensive functional reinnervation 
has been documented (5) as early as 9 to 12 months after 
autotransplantation, catecholamine content of the trans•
planted heart was found to be depressed when measured in 
isolated sections of the heart as long as 5 years after the 
operation. Our study extends these observations to 12 years 
and shows that both norepinephrine and epinephrine con•
tents are still low «50% of normal values). These findings 
are best explained by the presence of limited sympathetic 
catecholamine-containing nerve endings. Thus, it appears 
that the physiologic responses reported (6) to occur after 
cardiac reinnervation are mediated by small numbers of 
sympathetic neurons. Another explanation for this disparity 
between physiologic adrenergic responses and myocardial 
tissue norepinephrine may be that norepinephrine content 
does not directly reflect the degree of physiologic adrenergic 
response that can be obtained acutely. Kay and Tyce (18) 
have shown that radiolabeled norepinephrine uptake is a 
more accurate functional indicator of cardiac sympathetic 
reinnervation than is heart tissue norepinephrine content. In 
addition, there may be changes in the number of adrenergic 
receptors in the heart which could compensate for decreased 
catecholamine release. 
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Effect of cardiac denervation on myocardial dopa•
mine concentrations. Our findings on myocardial tissue 
dopamine provide some important insight not only on the 
effect of cardiac denervation on dopamine levels but also 
on the influence of reinnervation on dopamine concentra•
tions in the heart. First, in short-term denervated hearts 
substantial dopamine stores were demonstrated while nor•
epinephrine and epinephrine were virtually depleted. This 
suggests that myocardial dopamine, unlike norepinephrine, 
is not dependent mainly on intact adrenergic nerves. It is 
possible that non-neuronal dopamine stores in the heart re•
flect dopamine production by a non-neuronal process similar 
to that in the kidney (11,19). Second, although the dopamine 
concentration in long-term autotransplanted hearts tended 
to be higher than in short-term norepinephrine-depleted hearts, 
the difference was not statistically significant. In contrast, 
norepinephrine concentration showed a distinct increase in 
the long-term versus short-term periods after transplanta•
tion, suggesting a close relation of norepinephrine, but not 
of dopamine, with the sympathetic reinnervation that occurs 
with time after transplantation. 
Although it seems likely that dopamine in cardiac tissue 
is predominantly independent of adrenergic nerves, a ten•
dency for reduction in dopamine concentration in acutely 
denervated hearts suggests that dopamine production in the 
heart is, in part, neuronally mediated. In pathologic states 
such as heart failure, in which norepinephrine is markedly 
decreased (15,16), the relative concentrations of dopamine 
are increased (20). Thus, in a situation in which norepi•
nephrine is depleted, dopamine content in cardiac tissue may 
not be depleted because of I) dopamine production in the 
heart independent of noradrenergic activity (21), or 2) do•
pamine accumulation resulting from beta-hydroxylase in•
hibition (22). 
Significance of preserved myocardial dopamine con•
centrations. Our findings suggest that dopamine functions 
in the heart not only as a precursor of norepinephrine in 
adrenergic presynaptic vesicles but also as a terminal bio•
synthetic product. Drake et al. (23) measured dopamine 
binding sites and tyrosine hydroxylase in denervated myo•
cardium and found a decrease in binding sites for dopamine 
as well as the amount of rate-limiting enzyme tyrosine hy•
droxylase. These observations led them to conclude that 
dopamine is most likely synthesized in the myocardium 
independent of adrenergic nerves. I1ebekk et al. (21) pro•
vided further evidence to support release of dopamine from 
myocardium in a pig model by demonstrating that under 
stable hemodynamic conditions there was a higher coronary 
sinus dopamine content and a positive venous-arterial dif•
ference. Thus, dopamine stores in the heart may be deter•
mined, at least in part, by a change in the rate-limiting step 
for myocardial norepinephrine synthesis (22). 
Pierpont et al. (20) observed that dopamine accumulates 
in the presence of norepinephrine depletion in human cardiac 
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tissue in severe congestive heart failure, which may suggest 
an inability to hydroxylate dopamine to norepinephrine; 
therefore, norepinephrine is depleted and dopamine accu•
mulates. The amount of dopamine in myocardium in our 
study remained relatively unaffected by denervation due to 
autotransplantation and thus confirmed earlier observations 
(24) on the effect of cardiac denervation on myocardial 
dopamine. Because the number of high affinity binding sites 
for dopamine and the amount of tyrosine hydroxylase remain 
unchanged with denervation (23), it is likely that dopamine 
synthesis in the denervated myocardium accounts for rela•
tively well preserved dopamine concentration in myocardial 
tissue despite norepinephrine depletion. 
We thank Bruce Bailon for technical assistance, Shirley McCray for sec•
retarial help in typing the manuscript and Mary G. Guidon for illustrations. 
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